CTRI/2021/10/037068已完成未知
A study to evaluate the effect of Alpha Lipoic acid on neuropathic symptoms and inhibition of Platelet aggregation in diabetic neuropathy patients on Gabapentin/ Pregabalin
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Type 2 diabetic patients of either sex aged between 30 - 65 years
- •2. Symptomatic diabetic polyneuropathy patients with VPT value more than 15V
- •3. HbA1c < 10%
- •4. Patients on stable dose of antidiabetic drug or combination of Metformin + sulphonyl urea + DPP4 Inhibitors for the past 3 months
- •5. Patients on stable dose of Gabapentin 300 mg BD or Pregabalin 75mg BD for past 3 months
- •6. Serum creatinine < 2 mg/dl.
排除标准
- •1. Any other conditions causing neuropathic pain
- •2. History of hypersensitivity to alpha Lipoic acid
- •3. Patients receiving other antioxidants.
- •4. Patients on antiplatelet drugs
- •5. Patients with active cardiovascular disease
- •6. Patients with clinically significant skin disease
- •7. Pregnant and lactating women.
研究者
相似试验
已完成
不适用
To evaluate the effect of Alpha lipoic acid on platelet aggregation in diabetic neuropathy patientsCTRI/2022/02/040276Indian council of Medical Research52
已完成
不适用
Effect of Alpha Lipoid Acid in Diabetic Neuropathy patientsCTRI/2020/10/028346Dr Kammila Sireesha52
尚未招募
4 期
Management of Burning Mouth in Type II-Diabetes MellitusCTRI/2020/01/022786S Rajkumari
已完成
3 期
Effects of alpha lipoic acid on ß- Thalassemia Majorß-thalassemia Major.Beta thalassaemiaIRCT2017061714237N2Kermanshah University of Medical Sciences30
尚未招募
3 期
The effect of alpha lipoic acid on neuropathy in patients with type 2 diabetesDiabetes - type 2.Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecifiedE08.40IRCT20230303057599N2Tehran University of Medical Sciences80